Edwards Lifesciences - Medical Technology Group Surprises With Very Strong Figures Thanks to Rising Routine Procedures!
Reading Time: 1 minute
Business drivers: Edward Lifesciences (EW) is one of the leading providers in the medical technology sector. It is particularly well positioned in heart valves, disposable cannulas for bypasses, and monitoring solutions. As the number of routine procedures such as bypass operations is picking up again significantly, the outlook for Edward Lifesciences is also brightening. On July 24, Edward Lifesciences surprised with very strong Q2 figures. At 69 cents (previous year: 62 cents), adjusted EPS was well above the consensus expectation of 62...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
